Back to compounds

COMPOUND PROFILE / PROTEINS & BIOLOGICS

HGH 191AA / Somatropin.

Research draft

HGH 191AA refers to the 191-amino-acid human growth-hormone sequence; approved recombinant versions are somatropin.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Identity and evidence review notes

Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.

Overview

HGH 191AA refers to the 191-amino-acid human growth-hormone sequence; approved recombinant versions are somatropin.

CLASSIFICATIONProteins & biologics
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

Somatropin activates growth-hormone receptors and downstream IGF-1 signalling.

Human research

Clinical evidence supports particular deficiency and growth-disorder indications. It does not establish healthy-user longevity benefit.

Preclinical & other research

Mechanistic growth research is extensive but does not authenticate a supplier's vial.

Safety & unknowns

Fluid retention, joint symptoms and glucose effects are relevant; approved-product warnings apply.

Regulatory status

Keep this market-labelled entry linked to Somatropin, while treating supplier authenticity separately.

Reported use & evidence

Research profile draft

The supplied HGH 191AA / Somatropin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds